Business
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
After opening lower, the Nifty Pharma index reversed losses and climbed nearly 1% to cross the 25,000 mark. The sectoral index also touched a fresh 52-week high of 25,043 during early trade before trimming some gains.
The Indian currency fell to 96.96 per dollar, breaching its all-time low of 96.6150 hit in the previous session. The currency is down 6% since the Iran war began in late February. A falling rupee is typically considered a positive for the export-heavy pharma sector.
Top pharma gainers today
Zydus Lifesciences shares were the top gainers on the index, jumping over 7% to hit a fresh 52-week high of Rs 1,091 apiece on NSE after the pharma company reported a 9% year-on-year (YoY) rise in consolidated net profit to Rs 1,272.5 crore for the January-March quarter of FY26. Revenue from operations, meanwhile, rose more than 16% YoY to Rs 7,587 crore during the quarter under review.Along with the Q4 results, Zydus Lifesciences announced its biggest-ever share buyback worth Rs 1,100 crore via the tender route at a buyback price of Rs 1,150 per share, offering nearly a 13% premium over the stock’s previous closing price. Its board has also recommended a final dividend of Re 1 per share (100%) on a face value of Re 1 each, subject to shareholders’ approval at the company’s Annual General Meeting scheduled for August 11.
Mankind Pharma shares followed, surging over 3%. This comes after the company reported a 32% YoY rise in consolidated net profit to Rs 554 crore for the fourth quarter of the financial year 2026, from Rs 421 crore in the corresponding quarter of the previous financial year. The firm’s revenue from operations rose 12% YoY to Rs 3,443 crore during the quarter under review.
Laurus Labs, Aurobindo Pharma, and Biocon shares gained around 1% each, while those of Lupin, Sun Pharma, Cipla, Torrent Pharma, and Divi’s Laboratories were trading in the green with marginal gains, as seen at 11 am. Bucking the trend, however, Ajanta Pharma, Piramal Pharma, Gland Pharma, Dr Reddy’s Labs, Abbot India, Glenmark, Alkem Labs, and IPCA Labs shares fell up to 1%.
What lies ahead?
Nifty Pharma’s technical structure remains constructive after the index touched a fresh 52-week high today, according to Harshal Dasani, Business Head at INVasset PMS, who said that this is significant as it has come at a time when the broader market is still dealing with global risk-off pressure, currency weakness, and uneven earnings delivery. The relative strength in pharma counters suggests capital is rotating into sectors with better earnings visibility, not merely chasing momentum, he added.“The index has been forming a clear higher-high, higher-low pattern, and the latest breakout keeps the medium-term trend in favour of buyers as long as it holds above the recent breakout zone. The immediate support now sits around 24,700 to 24,800, while a stronger cushion is visible near 24,400. A close below that band would weaken the breakout and indicate profit-booking rather than trend continuation,” according to Dasani.
The risk-reward remains favourable, but the entry point is no longer fresh after a sharp move, the analyst said. “The cleaner setup would come on controlled pullbacks rather than vertical rallies. The key confirmation from here is breadth. If participation remains broad across large pharma, domestic formulations and speciality businesses, the breakout could extend. If leadership narrows, the index may pause before attempting the next leg,” he added.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Business
Citizens raises Rithm Capital stock price target on asset growth

Citizens raises Rithm Capital stock price target on asset growth
Business
Citizens raises Relay Therapeutics price target on strong trial data

Citizens raises Relay Therapeutics price target on strong trial data
Business
Kwinana Rail Loop proposal advances
About 126 hectares of land has been earmarked for a rezoning, to create a new freight corridor as a replacement to the constrained Kwinana Triangle network.
Business
At Close of Business podcast May 20 2026
Sam Jones and Nadia Budihardjo discuss the recent Business News lawyers feature.
Business
Indonesia central bank delivers hefty interest rate rise as it looks to stem battered rupiah’s fall

Indonesia central bank delivers hefty interest rate rise as it looks to stem battered rupiah’s fall
Business
Earnings-Fueled Stock Rally Faces Key Test
Blockbuster earnings helped carry stocks to new highs in recent weeks. Now, reports from major retailers and the world’s most-valuable company pose a fresh test.
Nvidia NVDA -0.77%decrease; red down pointing triangle, the chip maker whose staggering size has given it an outsize impact on the direction of the stock market, fell 1.3% on Monday, ahead of Wednesday’s quarterly results. Tech stocks dragged on major indexes Monday, with the Nasdaq composite losing 0.5%.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Business
MYR Group: Hidden Backlog Arbitrage And The Impending Labor Trap (NASDAQ:MYRG)
A trader, researcher, and analyst possessing experience spanning years in the domains of US stocks, transnational equities, global indexes, commodities, FX/interest securities, cryptocurrencies, ETFs, options, futures, and CFDs. My expertise encompasses fundamental analysis, technical analysis, quantitative analysis, portfolio management, investment/capital mapping, and programming.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Business
JBBB: The Yield Is Real, But So Is The CLO Risk
JBBB: The Yield Is Real, But So Is The CLO Risk
Business
China-U.S. Agriculture Pact Could Miss the Target, Just Like Last Time
China’s new pledge to buy more American farm products helped send soybean, corn, and wheat prices sharply higher Monday, reviving hopes that U.S. agriculture exports could rebound after collapsing in 2025. But investors may want to temper their excitement.
Business
Exposure Across Pharma, Defense and Infrastructure
LONDON — Several FTSE 100 companies have gained attention in 2026 for their exposure to artificial intelligence applications, ranging from drug discovery to infrastructure support and data analytics, even as the index itself has limited direct pure-play AI representation.
AstraZeneca stands out for its integration of AI into pharmaceutical research. The company acquired Boston-based Modella AI in early 2026 to support oncology research with AI agents. It also partnered on AI-driven platforms for weight-loss drug development. AstraZeneca, one of the largest companies in the index by market capitalization, has used AI to accelerate aspects of its pipeline.
Rolls-Royce Holdings benefits from AI through its work on infrastructure and advanced engineering. The company supports data center and energy needs tied to AI computing demands. Its aerospace and power systems divisions have seen interest linked to broader AI ecosystem requirements. Rolls-Royce shares have performed strongly in 2026 amid industrial recovery.
BAE Systems provides defense technology with growing AI applications in systems and analytics. The company has seen gains in 2026 as one of the top FTSE 100 performers, partly tied to demand for advanced capabilities that incorporate AI elements in security and military contexts.
Rio Tinto supplies critical materials such as copper and aluminum essential for AI infrastructure, including data centers and power networks. As a leading mining company, its output supports the physical buildout of AI-related facilities. The firm has been highlighted for its role in the AI supply chain.
Halma specializes in safety, environmental and analytical technologies, including components relevant to AI-driven systems and facilities. The company provides sensors, photonics and related tools that support data center operations and industrial AI applications.
These five companies illustrate how FTSE 100 firms participate in the AI theme indirectly. The index overall has lower direct exposure compared to U.S. benchmarks, with gains often driven by commodity, defense and healthcare sectors that intersect with AI growth.
AstraZeneca’s market capitalization exceeded £220 billion earlier in 2026. The company continues clinical development while incorporating AI tools for research efficiency. Its oncology and respiratory pipelines have drawn analyst focus alongside AI initiatives.
Rolls-Royce reported strong results in 2026, contributing to FTSE 100 advances. Its civil aerospace and power systems segments align with rising energy demands from AI training and inference. The company has emphasized long-term contracts and operational improvements.
BAE Systems ranked among the strongest FTSE 100 performers in early 2026, with shares rising significantly year to date. Defense spending trends and technology integration have supported its position. The firm delivers systems across air, land and sea domains with increasing digital and AI-adjacent features.
Rio Tinto operates large-scale mining assets worldwide, producing metals vital for electrification and computing hardware. Copper demand has been linked to data center expansion. The company maintains operations in iron ore, aluminum and other commodities.
Halma’s portfolio includes businesses in safety sensors and photonics, areas that support high-tech facilities. The firm has a track record of consistent growth through acquisitions and organic expansion in specialized markets.
Other FTSE 100 names with noted AI ties include London Stock Exchange Group (LSEG) and RELX. LSEG provides financial data and analytics platforms that incorporate AI tools. RELX, through its information and analytics businesses, has applied AI across legal, scientific and risk sectors. Fund managers have described these as potential beneficiaries despite earlier concerns over disruption.
The FTSE 100 reached record levels in 2026, supported by diversified sectors amid global AI enthusiasm. The index gained nearly 22 percent in 2025 and continued upward momentum into the new year, partly reflecting indirect AI tailwinds through commodities and industrials.
Investors access these stocks via the London Stock Exchange. Share prices fluctuate with company results, commodity cycles, defense budgets and pharmaceutical pipelines. Dividend yields vary, with many FTSE 100 constituents offering payouts alongside growth exposure.
AstraZeneca trades under ticker AZN on the LSE. Rolls-Royce uses RR., BAE Systems BA., Rio Tinto RIO and Halma HLMA. Official company reports and regulatory filings provide performance data.
Broader market context includes global AI spending by technology firms. FTSE 100 companies position themselves through supply chains, applications and enabling technologies rather than core chip or model development.
Analysts monitor quarterly results for updates on AI-related progress. AstraZeneca’s acquisitions and partnerships have featured in earnings commentary. Rolls-Royce and BAE have highlighted order books and technology investments.
Mining firms like Rio Tinto report on production volumes and market demand tied to technology infrastructure. Halma updates on sector-specific growth in safety and analytics.
The London Stock Exchange Group has faced questions over AI impacts on data services but reported resilient performance. Its platforms support trading and analytics that increasingly use AI enhancements.
FTSE 100 constituents collectively offer diversified exposure. While U.S. indices feature prominent AI leaders, the UK benchmark provides access to supporting industries and established multinationals.
Trading volumes and analyst coverage remain active for these names. Institutional investors track AI themes across sectors. Retail access occurs through standard brokerage accounts or index funds with FTSE 100 weighting.
As of May 2026, these stocks reflect ongoing developments in their respective fields. Company disclosures detail specific AI initiatives where applicable. Investors review latest financial statements and presentations for detailed exposure.
The FTSE 100’s composition favors established industries with AI adjacency. This structure has contributed to relative stability compared to more concentrated technology indices.
Further information is available through company websites, LSE announcements and regulatory bodies. Market data providers track performance metrics including price, volume and dividends.
-
Crypto World4 days agoBloFin War of Whales 2026 Grand Prix opens registration for $5M trading championship
-
Fashion5 days agoWeekend Open Thread: Theory – Corporette.com
-
Crypto World5 days agoE-Estate Announces 1 Year Live: Washington DC Summit as Real Estate Tokenization Enters Its Next Phase
-
Tech5 days agoTech Moves: Microsoft AI leader jumps to OpenAI; former AI2 exec joins Meta; and more
-
Tech4 days agoGoogle reimburses Register sources who were victims of API fraud
-
Crypto World6 days agoGoogle’s Gemini AI Predicts Incredible Solana Price by the End of 2026
-
Business5 days agoH&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
-
Sports4 days agoNapoleonic enters 2026 Doomben 10,000 field via Abounding withdrawal
-
Entertainment6 days agoZara Larsson Has Blunt Response To Chris Brown Diss
-
Crypto World6 days agoTwo AI Tokens Lead May Rally, But Risks Are Rising
-
Crypto World4 days agoBeInCrypto 100 Institutional Awards Nomination: KAST for Best Digital Assets Neobank and Best Digital Assets Fintech
-
Fashion3 days agoOn the Scene at Gucci’s Cruise Show in New York City: Mariah Carey, Kim Kardashian, Lindsay Lohan, Iman, and More!
-
Crypto World4 days agoBitcoin Battles US Bond Nerves With BTC Price Dip Toward New May Lows
-
Crypto World4 days agoWall Street’s Boldest Gold Prediction Has Russians Rushing to Buy
-
Politics5 days agoDWP PIP Timms review continues to be an absolute farce
-
Fashion4 days agoTrending Western Style Vests Perfect for Summer
-
Entertainment5 days agoDavid Letterman Returns to Late Show, Blasts Cancellation
-
Crypto World4 days agoICE and CME urge US regulators to curb Hyperliquid energy trading
-
Crypto World5 days agoLido Finance Selects Chainlink CCIP as the Official Cross-Chain Infrastructure for wstETH Security
-
Fashion3 days agoAmazon Sundays: Memorial Day Hosting

You must be logged in to post a comment Login